why choose us

First received: September 25, 2023

Clinical Trial: A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Generalized Myasthenia Gravis

Study Type: INTERVENTIONAL


Official Title: An Open-label, Single-arm Study Evaluating the Activity, Safety, and Pharmacokinetics of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

Brief Summary: The purpose of the study is to assess the safety and tolerability of subcutaneous (sc) administration of rozanolixizumab in pediatric participants aged ?2 to \

Read more